US5691203A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for serum-free culture of human vascular endothelial cells
Assignee: Kurashiki Spinning Co Ltd
•
Filing: 1993-09-29
•
Granted: 1997-11-25
•
Expires: 2013-09-29
Abstract
Abstract Animal adhesive cells, particularly human vascular endothelial cells, are cultured in serum-free condition by coating at least one polymer having cell adhesive activity on an inner surface of a culture vessel or surface of a carrier for cell culture, and culturing the cells in the coated vessel or with the coated carrier using a serum-free medium for animal cell culture containing isolated serum albumin, and preferably also transferrin. The polymer is a synthetic polymer modified with a peptide having cell adhesive activity or a natural polymer having cell adhesive activity or a combination thereof. Preferably, the peptide is RGDV, RGDS, RGDN, DGEA or YIGSR and the natural polymer is collagen, gelatin, keratin, fibronectin, vitronectin or laminin. A preferred medium for culturing human vascular endothelial cells is basal medium MCDB 131 or MCDB 107 containing isolated serum albumin, transferrin, hydrocortisone and epithelial growth factor.
Inventors
- 👤 Susumu Katsuen
- 👤 Kunihiro Ohshima
- 👤 Ryohei Yamamoto
- 👤 Toyokazu Nishino
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:53
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/069; C12N5/0068; C12N2500/00; C12N2500/70; C12N2500/80; C12N2500/84; C12N2500/90; C12N2501/00; C12N2501/10; C12N2501/11; C12N2501/30; C12N2501/38; C12N2501/39; C12N2533/00; C12N2533/30; C12N2533/50; C12N2533/54
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
142 words
A method for culturing human vascular endothelial cells in serum free condition comprising 1) coating at least one polymer having cell adhesive activity to adhere cells to a surface on at least a part of an inner surface of a culture vessel of surface of a carrier for cell culture, wherein said at least one polymer is a synthetic polymer modified with a peptide having cell adhesive activity, or a natural polymer having cell adhesive activity, or a combination thereof, and 2) culturing the human vascular endothelial cells in the coated vessel or with the coated carrier using a serum-free medium for human vascular endothelial cell culture containing at least (i) serum albumin isolated from serum, (ii) transferrin, (iii) hydrocortisone, and (iv) epithelial growth factor whereby initial adhesion of said cells to said polymer coating and viability of said cells are increased.
Claim 2
Independent Claim
142 words
A method for culturing human vascular endothelial cells in serum free condition comprising 1) coating at least one polymer having cell adhesive activity to adhere cells to a surface on at least a part of an inner surface of a culture vessel of surface of a carrier for cell culture, wherein said at least one polymer is a synthetic polymer modified with a peptide having cell adhesive activity, or a natural polymer having cell adhesive activity, or a combination thereof, and 2) culturing the human vascular endothelial cells in the coated vessel or with the coated carrier using a serum-free medium for human vascular endothelial cell culture containing at least (i) serum albumin isolated from serum, (ii) transferrin, (iii) hydrocortisone, and (iv) epithelial growth factor whereby initial adhesion of said cells to said polymer coating and viability of said cells are increased.
Claim 3
Dependent Claim
32 words
A method as claimed in claim 1, wherein the polymer having cell-adhesive activity is a mixture of the natural polymer and the synthetic polymer modified with a peptide having cell adhesive activity.
Claim 4
Dependent Claim
25 words
The method as claimed in claim 1, wherein the natural polymer is selected from the group consisting of collagen, gelatin, keratin, fibronectin, vitronectin, and laminin.
Claim 5
Dependent Claim
29 words
The method as claimed in claim 1, wherein the peptide having cell adhesive activity is selected from the group consisting of Arg-Gly-Asp-Val, Arg-Gly-Asp-Ser, Arg-Gly-Asp-Asn, Asp-Gly-Glu-Ala, Tyr-Ile-Gly-Ser-Arg, and mixtures thereof.
Claim 6
Dependent Claim
612 words
The method as claimed in claim 1, wherein the serum-free medium comprises a basal medium selected from the group consisting of MCDB 131 and MCDB 107, wherein medium MCDB 131 comprises 2.67 mg/L of L-Alanine, 63.20 mg/L of L-Arginine.HCl, 2.67 mg/L of L-Alanine, 63.20 mg/L of L-Arginine .HCl, 15.01 mg/L of L-Asparagine H 2 O, 13.31 mg/L of L-Aspartic acid, 35.13 mg/L of L-Cysteine.HCl-H 2 O, 4.41 mg/L of L-Glutamic acid, 1461.50 mg/L of L-Glutamine, 2.25 mg/L of Glycine, 41.93 mg/L of L-Histidine.HCl.H 2 O, 65.58 mg/L of L-Isoleucine, 131.27 mg/L of L-Leucine, 181.65 mg/L of L-Lysine.HCl, 14.92 mg/L of L-Methionine, 33.04 mg/L of L-Phenylalanine, 11.51 mg/L of L-Proline, 31.53 mg/L of L-Serine, 11.91 mg/L of L-Threonine, 4.08 mg/L of L-Tryptophan, 18.12 mg/L of L-Tyrosine, 117.15 mg/L of L-Valine, 0.00733 mg/L of D-Biotin, 0.602 mg/L of Calcium folinate.5H 2 O, 0.002063 mg/L of α-Lipoic acid, 6.11 mg/L of Nicotinamide, 11.91 mg/L of D-Pantothenic acid (hemi-Ca salt), 2.056 mg/L of Pyridoxine.HCl, 0.003764 mg/L of Ribmg/L oflavin, 3.373 mg/L of Thiamine.HCl, 0.01355 mg/L of Vitamine B 12 , 0.1351 mg/L of Adenine, 13.96 mg/L of Choline chloride, 1000.00 mg/L of D-Glucose, 7.21 mg/L of i-Inositol, 0.0001611 mg/L of Putrescine, 110.04 mg/L of Sodium pyruvate, 0.02422 mg/L of Thymidine, 235.23 mg/L of CaCl 2 .2H 2 O, 298.20 mg/L of KCl, 2463.8 mg/L of MgSO4.7H 2 O, 6430.0 mg/L of NaCl, 134.04 mg/L of Na 2 HPO 4 .7H 2 O, 0.001248 mg/L of CuSO 4 .5H 2 O, 0.2780 mg/L of FeSO 4 .7H 2 O, 0.000241 mg/L of MnSO 4 .5H 2 O, 0. 00371 mg/L of (NH 4 ) 6 Mo 7 O 24 .H 2 O, 0000713 mg/L of NiCl 2 .6H 2 O, 0.00387 mg/L of H 2 SeO 3 , 2.842 mg/L of NaSiO 3 .9H 2 O, 0.000585 mg/L of NH 4 VO 3 , 0.0002875 mg/L of ZnSO 4 .7H 2 O, 1176.0 mg/L of NaHCO 3 , 12.42 mg/L of Phenol red (Sodium salt); and MCDB 107 comprises 8.909 mg/L of L-Alanine, 210.7 mg/L of L-Arginine.HCl, 15.07 mg/L of L-Asparagine.H 2 O, 13.31 mg/L of L-Aspartic acid, 8.78 mg/L of L-Cysteine.HCl, 14.71 mg/L of L-Glutamic acid, 365.3 mg/L of L-Glutamine, 22.521 mg/L of Glycine, 20.97 mg/L of L-Histidine.HCl.H 2 O, 3.939 mg/L of L-Isoleucine, 13.12 mg/L of L-Leucine, 36.54 mg/L of L-Lysine HCl, 4.476 mg/L of L-Methionine, 4.956 mg/L of L-Phenylalanine, 34.53 mg/L of L-Proline, 10.51 mg/L of l-Serine, 11.91 mg/L of L-Threonine, 2.042 mg/L of L-Tryptophan, 5.436 mg/L of L-Tyrosine, 11.72 mg/L of L-Valine, 0.0073 mg/L of Biotin, 0.0006 mg/L of Folinic acid, 0.0021 mg/L of Lipoic acid, 6.105 mg/L of Nicotinamide, 0.2383 mg/L of Pantothenate Ca, 0.062 mg/L of Pyridoxine.HCl, 0.113 mg/L of Ribmg/L oflavin, 0.337 mg/L of Thiamine.HCl, 0.136 mg/L of Cyanocobalamine, 25.32 mg/L of Choline ditertrate, 18.02 mg/L of Inositol, 4.0437 mg/L of Adenine.SO 4 , 0.0028 mg/L of Linoleic acid, 0.00016 mg/L of Putrescine.2HCl, 0.0727 mg/L of Thymidine, 6640.08 mg/L of NaCl, 149.12 mg/L of KCl, 111 mg/L of CaCl 2 , 120.33 mg/L of MgSO 4 , 720.64 mg/L of Glucose, 110 mg/L of Sodium Pyruvate, 408.3 mg/L of KH 2 PO 4 , 0.00025 mg/L of CuSO 4 , 1.39 mg/L of FeSO 4 .7H 2 O, 0.00024 mg/L of MgSO 4 .7H 2 O, 0.00124 mg/L of (NH 4 ) 6 Mo 7 O 24 .4H 2 O,0.00012 mg/L of NiCl 2 .6H 2 O, 0.00387 mg/L of Na 2 SeO 3 , 0.061 mg/L of NaSiO 3 , 0.000113 mg/L of SnCl 2 .2H 2 O, 0.000585 mg/L of NH 4 VO 3 , 0.144 mg/L of ZnSO 4 .7H 2 O, 1.242 mg/L of Phenol red.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-11-24 | 2001-05-26 | 2001-11-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-11-24 | 2005-05-26 | 2005-11-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-11-24 | 2009-05-26 | 2009-11-25 | $7700.00 | Window Closed / Lapsed |